Advanced Medical Optics to Present at Two Investor Conferences in January 2007

Date : 01/02/2007 @ 3:08PM
Source : PR Newswire
Stock : Advanced Med Optics (EYE)
Quote : 6.83  -3.07 (-31.01%) @ 8:00PM
<< BackQuote Chart Financials

 



Advanced Medical Optics to Present at Two Investor Conferences in January 2007

SANTA ANA, Calif., Jan. 2 /PRNewswire-FirstCall/ -- Advanced Medical Optics, Inc. (AMO) (NYSE:EYE), today announced that Corporate Vice President, Research and Development Leonard Borrmann, will present an overview of the company and an update of R&D activities at the Morgan Stanley Pharmaceutical CEOs Unplugged Conference in New York City on Thursday, January 4 at 8:45am ET.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO)

AMO Chairman, President and CEO Jim Mazzo is also scheduled to provide a corporate overview at the 25th Annual JP Morgan Healthcare Conference in San Francisco on Thursday, January 11 at 6:30am ET.

To access an audio webcast of these presentations, please visit AMO's Investors site at http://www.amo-inc.com/.

About Advanced Medical Optics (AMO)

AMO is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. AMO owns or has the rights to such ophthalmic surgical product brands as ReZoom(TM), Clariflex(R), Sensar(R), CeeOn(R), Tecnis(R) and Verisyse(TM) intraocular lenses, STAR S4 IR(TM) laser vision correction system, WaveScan Wavefront(R) System, CustomVue(TM) procedure, Sovereign(R) and Sovereign(R) Compact(TM) phacoemulsification systems with WhiteStar(R) technology, Amadeus(TM) and Amadeus(TM) II microkeratomes, Healon(R) viscoelastics, and the Baerveldt(R) glaucoma shunt. Products in the contact lens care line include disinfecting solutions, enzymatic cleaners and lens rewetting drops. Among the eye care product brands the company possesses are COMPLETE(R) Moisture PLUS(TM), COMPLETE(R) Blink-N-Clean(R), Consept(R)F, Consept(R) 1 Step, Oxysept(R) 1 Step, UltraCare(R), Ultrazyme(R), Total Care(TM) and blink(TM) branded products. Amadeus is a licensed product of, and a trademark of, SIS, Ltd. AMO is based in Santa Ana, California, and employs approximately 3,800 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries. For more information, visit the company's Web site at http://www.amo-inc.com/.

Investor Contact: Sheree Aronson (714) 247-8290

http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO

http://photoarchive.ap.org/

DATASOURCE: Advanced Medical Optics, Inc.

CONTACT: Investors, Sheree Aronson of Advanced Medical Optics, Inc.,

+1-714-247-8290,

Web site: http://www.amo-inc.com/

<< Back


Advanced Med Optics Historical Chart Advanced Med Optics Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
39 site:2us 081012 02:12 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )